FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200507834> ?p ?o ?g. }

• W4200507834 endingPage "8" @default.
• W4200507834 startingPage "1" @default.
• W4200507834 abstract "Multiple myeloma (MM) is the second most common hematologic malignancy and requires long-term and high-dose corticosteroid-based chemotherapy. The aim of this study was to investigate the prevalence and clinical predictors of corticosteroid-associated adrenal insufficiency (AI) in patients with MM receiving long-term chemotherapy. This retrospective study included patients with MM who were administered corticosteroid-based chemotherapy and underwent a rapid adrenocorticotropic hormone (ACTH) stimulation test between 2005 and 2018. AI was determined by a peak cortisol value < 18 μg/dL after ACTH stimulation. Demographic, clinical, and laboratory parameters were evaluated, and the prevalence and clinical risk factors of AI were examined. Of 282 patients with MM who received corticosteroid-based chemotherapy, 142 patients (50.4%) were classified as having AI. There were no differences in age, sex, body mass index, comorbidities, and laboratory findings, including serum sodium levels between the AI and no-AI groups. In univariate analysis, the cumulative dose of corticosteroid (odds ratio (OR) = 0.99, 95% confidence interval (CI) 0.98-0.99; P = 0.020) and megestrol acetate use (OR = 2.63, 95% CI 1.48-4.67; P = 0.001) were associated with the occurrence of AI. Cumulative duration and cumulative dose per duration of corticosteroid use were not associated with the occurrence of AI. However, in the multivariate analysis, only megestrol acetate use was associated with an increased risk of AI (OR = 2.54, 95% CI 1.41-4.60; P = 0.002). Approximately 95.8% of patients with AI had suspicious symptoms or signs of AI. Although clinical symptoms and signs are usually nonspecific, symptomatic patients with MM receiving long-term corticosteroid therapy have sufficient potential for developing AI, particularly when receiving megestrol acetate. These findings can help alert clinicians to consider adrenal suppression following corticosteroid-based chemotherapy in patients with MM." @default.
• W4200507834 created "2021-12-31" @default.
• W4200507834 creator A5016252074 @default.
• W4200507834 creator A5017156593 @default.
• W4200507834 creator A5023933695 @default.
• W4200507834 creator A5026777852 @default.
• W4200507834 creator A5041987846 @default.
• W4200507834 creator A5044367462 @default.
• W4200507834 creator A5064371755 @default.
• W4200507834 creator A5068416755 @default.
• W4200507834 creator A5069818368 @default.
• W4200507834 date "2021-12-13" @default.
• W4200507834 modified "2023-09-23" @default.
• W4200507834 title "Prevalence and Risk Factors for Adrenal Insufficiency in Patients with Multiple Myeloma Receiving Long-Term Chemotherapy including Corticosteroids: A Retrospective Cohort Study" @default.
• W4200507834 cites W1817925071 @default.
• W4200507834 cites W1964889552 @default.
• W4200507834 cites W1972810095 @default.
• W4200507834 cites W1976008242 @default.
• W4200507834 cites W1997385239 @default.
• W4200507834 cites W2020190536 @default.
• W4200507834 cites W2022140603 @default.
• W4200507834 cites W2023041900 @default.
• W4200507834 cites W2055864845 @default.
• W4200507834 cites W2101887066 @default.
• W4200507834 cites W2119948136 @default.
• W4200507834 cites W2120678876 @default.
• W4200507834 cites W2126111375 @default.
• W4200507834 cites W2163559038 @default.
• W4200507834 cites W2185954894 @default.
• W4200507834 cites W2215816454 @default.
• W4200507834 cites W2234917292 @default.
• W4200507834 cites W2293356638 @default.
• W4200507834 cites W2618539381 @default.
• W4200507834 cites W2792498051 @default.
• W4200507834 cites W2885634029 @default.
• W4200507834 cites W2915920111 @default.
• W4200507834 cites W2939993362 @default.
• W4200507834 cites W3096542929 @default.
• W4200507834 cites W3132722879 @default.
• W4200507834 cites W4210984474 @default.
• W4200507834 cites W4211037848 @default.
• W4200507834 cites W4211192934 @default.
• W4200507834 cites W4249152248 @default.
• W4200507834 doi "https://doi.org/10.1155/2021/2330417" @default.
• W4200507834 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34938804" @default.
• W4200507834 hasPublicationYear "2021" @default.
• W4200507834 type Work @default.
• W4200507834 citedByCount "3" @default.
• W4200507834 countsByYear W42005078342022 @default.
• W4200507834 countsByYear W42005078342023 @default.
• W4200507834 crossrefType "journal-article" @default.
• W4200507834 hasAuthorship W4200507834A5016252074 @default.
• W4200507834 hasAuthorship W4200507834A5017156593 @default.
• W4200507834 hasAuthorship W4200507834A5023933695 @default.
• W4200507834 hasAuthorship W4200507834A5026777852 @default.
• W4200507834 hasAuthorship W4200507834A5041987846 @default.
• W4200507834 hasAuthorship W4200507834A5044367462 @default.
• W4200507834 hasAuthorship W4200507834A5064371755 @default.
• W4200507834 hasAuthorship W4200507834A5068416755 @default.
• W4200507834 hasAuthorship W4200507834A5069818368 @default.
• W4200507834 hasBestOaLocation W42005078341 @default.
• W4200507834 hasConcept C126322002 @default.
• W4200507834 hasConcept C141071460 @default.
• W4200507834 hasConcept C144301174 @default.
• W4200507834 hasConcept C151032500 @default.
• W4200507834 hasConcept C156957248 @default.
• W4200507834 hasConcept C167135981 @default.
• W4200507834 hasConcept C2776694085 @default.
• W4200507834 hasConcept C2776804153 @default.
• W4200507834 hasConcept C2778065167 @default.
• W4200507834 hasConcept C2778129406 @default.
• W4200507834 hasConcept C2780221984 @default.
• W4200507834 hasConcept C2780546910 @default.
• W4200507834 hasConcept C38180746 @default.
• W4200507834 hasConcept C71315377 @default.
• W4200507834 hasConcept C71924100 @default.
• W4200507834 hasConcept C90924648 @default.
• W4200507834 hasConceptScore W4200507834C126322002 @default.
• W4200507834 hasConceptScore W4200507834C141071460 @default.
• W4200507834 hasConceptScore W4200507834C144301174 @default.
• W4200507834 hasConceptScore W4200507834C151032500 @default.
• W4200507834 hasConceptScore W4200507834C156957248 @default.
• W4200507834 hasConceptScore W4200507834C167135981 @default.
• W4200507834 hasConceptScore W4200507834C2776694085 @default.
• W4200507834 hasConceptScore W4200507834C2776804153 @default.
• W4200507834 hasConceptScore W4200507834C2778065167 @default.
• W4200507834 hasConceptScore W4200507834C2778129406 @default.
• W4200507834 hasConceptScore W4200507834C2780221984 @default.
• W4200507834 hasConceptScore W4200507834C2780546910 @default.
• W4200507834 hasConceptScore W4200507834C38180746 @default.
• W4200507834 hasConceptScore W4200507834C71315377 @default.
• W4200507834 hasConceptScore W4200507834C71924100 @default.
• W4200507834 hasConceptScore W4200507834C90924648 @default.
• W4200507834 hasLocation W42005078341 @default.
• W4200507834 hasLocation W42005078342 @default.
• W4200507834 hasLocation W42005078343 @default.
• W4200507834 hasLocation W42005078344 @default.
• W4200507834 hasOpenAccess W4200507834 @default.

• next